CNY 8.67
(-0.12%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Operating Cash Flow | 250.71 Million | -4.74 Billion | -13.71 Billion | -1.13 Billion | 2.99 Billion | 3.17 Billion |
Net Income | 1.19 Billion | 457.86 Million | 1.42 Billion | 1.13 Billion | 616.26 Million | 201.8 Million |
Depreciation & Amortization | 220.33 Million | 217.2 Million | 182.2 Million | 68.83 Million | 74.49 Million | 71.58 Million |
Deferred income taxes | 109.23 Million | -276.17 Million | 5.42 Million | -24.17 Million | -193.6 Million | -96.81 Million |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | -1.5 Billion | -6.78 Billion | -15.48 Billion | -2.51 Billion | 1.67 Billion | 2.15 Billion |
Other non-cash items | 668.89 Million | 1.36 Billion | 156.52 Million | 173.22 Million | 636.68 Million | 744.49 Million |
Investing Cash Flow | -147.2 Million | -105.24 Million | -196.2 Million | -110.1 Million | -85.73 Million | -63.46 Million |
Investments in PPE | -231.2 Million | -198.48 Million | -197.6 Million | -108.89 Million | -89.21 Million | -59.09 Million |
Acquisitions | 876.39 Thousand | 339.74 Thousand | 1.39 Million | 1.83 Million | 378.63 Thousand | - |
Investment purchases | - | -339.74 Thousand | - | - | -378.63 Thousand | -2.15 Million |
Sales/Maturities of investments | 322.05 Thousand | 13.09 Million | - | - | 3.1 Million | 778.59 Thousand |
Other Investing Activities | 82.79 Million | 80.15 Million | 0.35 | -3.04 Million | 378.63 Thousand | -2.98 Million |
Financing Cash Flow | -1.83 Billion | 4.15 Billion | 7.73 Billion | 11.21 Billion | -530.67 Million | -3.76 Billion |
Debt repayment | -870.77 Million | -27.87 Billion | -3.82 Billion | -2.87 Billion | -592.96 Million | -4.16 Billion |
Dividends payments | -219 Million | -478.24 Million | -339.68 Million | -220.61 Million | -203.1 Million | -514.09 Million |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | -194.71 Million | 32.96 Billion | 12.17 Billion | 14.46 Billion | 400.29 Million | 917.71 Million |
Accounts receivables | -2.1 Billion | -12.76 Billion | -26.48 Billion | -4.75 Billion | 5.85 Billion | -1.07 Billion |
Accounts payables | 467.73 Million | 6.38 Billion | 10.99 Billion | 2.42 Billion | -4.01 Billion | 3.32 Billion |
Inventory | 19.7 Million | -130.65 Million | 6.64 Million | -158.87 Million | 20.36 Million | -502.13 Thousand |
Other working capital | -53.33 Million | -276.17 Million | 5.42 Million | -24.17 Million | -193.6 Million | 2.15 Billion |
Cash at beginning of period | 17.93 Billion | 18.62 Billion | 24.81 Billion | 14.84 Billion | 12.46 Billion | 13.12 Billion |
Cash at end of period | 16.2 Billion | 17.93 Billion | 18.62 Billion | 24.81 Billion | 14.84 Billion | 12.46 Billion |
Capital Expenditure | -231.2 Million | -198.48 Million | -197.6 Million | -108.89 Million | -89.21 Million | -59.09 Million |
Effect of forex changes on cash | 599.3 Thousand | 2.64 Million | -657.13 Thousand | -1.58 Million | 402.29 Thousand | 1.01 Million |
Net cash flow / Change in cash | -1.72 Billion | -692.7 Million | -6.18 Billion | 9.96 Billion | 2.38 Billion | -656.49 Million |
Free Cash Flow | 19.5 Million | -4.94 Billion | -13.91 Billion | -1.24 Billion | 2.9 Billion | 3.11 Billion |
Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | 75.15 Million | 457.37 Million | 196.22 Million | 289.54 Million | 1.19 Billion | 162.46 Million |
Depreciation & Amortization | - | 65.34 Million | 65.34 Million | 62.7 Million | 220.33 Million | -85.32 Million |
Deferred income taxes | - | - | - | - | 109.23 Million | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | - | 3.96 Billion | - | -2.13 Billion | -1.5 Billion | 769.25 Million |
Other non-cash items | 4.24 Billion | 903.55 Million | 1.97 Billion | -380.6 Million | 668.89 Million | -415.56 Million |
Investing Cash Flow | 68.98 Million | -29 Million | -80.11 Million | -49.76 Million | -147.2 Million | -72.86 Million |
Investments in PPE | -27.56 Million | -25.51 Million | -52.21 Million | -114.32 Million | -231.2 Million | -48.38 Million |
Acquisitions | 45.94 Thousand | 4249.36 | 1220.42 | 755.73 Thousand | 876.39 Thousand | -26.87 Thousand |
Investment purchases | -52.6 Million | -61.37 Million | -62.33 Million | 265.37 Million | - | -83.82 Million |
Sales/Maturities of investments | 149.11 Million | 57.87 Million | 34.43 Million | -284.36 Million | 322.05 Thousand | 59.36 Million |
Other Investing Activities | 45.94 Thousand | -3.49 Million | -27.89 Million | 82.79 Million | 82.79 Million | 0.23 |
Financing Cash Flow | 901.58 Million | -1.05 Billion | -175.13 Million | -78.52 Million | -1.83 Billion | -185.6 Million |
Debt repayment | -910 Million | -315 Million | -82.35 Million | -23.65 Million | -870.77 Million | -9.22 Billion |
Dividends payments | -80.15 Million | -595.06 Million | -245.67 Million | -219 Million | -219 Million | -116.41 Million |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | 71.74 Million | -711.36 Million | -11.8 Million | -74.68 Million | -194.71 Million | 9.16 Billion |
Accounts receivables | - | 4.01 Billion | - | -2.1 Billion | -2.1 Billion | 811.2 Million |
Accounts payables | - | - | - | - | 467.73 Million | -27.76 Million |
Inventory | - | -24.31 Million | - | 19.7 Million | 19.7 Million | -41.95 Million |
Other working capital | - | -23.35 Million | - | -53.33 Million | -53.33 Million | 27.76 Million |
Cash at beginning of period | 18.32 Billion | 3.53 Billion | 16.2 Billion | 16.48 Billion | 17.93 Billion | 16.31 Billion |
Cash at end of period | 23.54 Billion | 4.18 Billion | 18.11 Billion | 16.2 Billion | 16.2 Billion | 16.48 Billion |
Capital Expenditure | -27.56 Million | -25.51 Million | -52.21 Million | -114.32 Million | -231.2 Million | -48.38 Million |
Effect of forex changes on cash | -842.43 Thousand | 230.94 Thousand | 71.95 Thousand | -610.84 Thousand | 599.3 Thousand | -249.03 Thousand |
Net cash flow / Change in cash | 5.21 Billion | 642.9 Million | 1.91 Billion | -282.66 Million | -1.72 Billion | 172.09 Million |
Free Cash Flow | 4.21 Billion | 1.27 Billion | 2.11 Billion | -268.09 Million | 19.5 Million | 382.43 Million |
HRMNYCP
3221
ASTRAZEN
603499
CAAP
KGSSF